JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$2.63B |
| 2 |
JPMorgan BetaBuilders Japan ETF
BBJP
|
+$1.83B |
| 3 |
JPMorgan BetaBuilders International Equity ETF
BBIN
|
+$1.55B |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$1B |
| 5 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$884M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core MSCI EAFE ETF
IEFA
|
+$1.8B |
| 2 |
iShares MSCI EAFE ETF
EFA
|
+$1.77B |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$884M |
| 4 |
iShares Core US Aggregate Bond ETF
AGG
|
+$880M |
| 5 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$834M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 26.09% |
| 2 | Technology | 16.19% |
| 3 | Financials | 10.76% |
| 4 | Healthcare | 10.54% |
| 5 | Consumer Discretionary | 10.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
4676
Suzano
SUZ
$10.5B
| $45K | ﹤0.01% |
6,739
-163,958
| -96% | -$1.2M |
2019 Q1
5 quarters
|
|
4677
Protara Therapeutics
TARA
$160M
| $45K | ﹤0.01% |
1,544
+1,292
| +513% | +$40K |
2020 Q1
1 quarter
|
|
4678
ReposiTrak
TRAK
$147M
| $45K | ﹤0.01% |
+10,651
| New | +$51.4K |
2020 Q2
0 quarters
|
|
4679
Universal Logistics Holdings
ULH
$487M
| $45K | ﹤0.01% |
2,608
+38
| +1% | +$540 |
2013 Q2
28 quarters
|
|
|
USX
4680
DELISTED
U.S. Xpress Enterprises, Inc. Class A Common Stock
USX
| $45K | ﹤0.01% |
7,476
+475
| +7% | +$2.17K |
2018 Q2
8 quarters
|
|
|
NBEV
4681
DELISTED
NewAge, Inc. Common Stock (Delaware)
NBEV
| $45K | ﹤0.01% |
29,775
+5,655
| +23% | +$8.44K |
2019 Q2
4 quarters
|
|
|
AIG.WS
4682
DELISTED
American International Group, Inc.
AIG.WS
| – | – |
0
| – | – |
2015 Q4
18 quarters
|
|
4683
Aquestive Therapeutics
AQST
$571M
| $44K | ﹤0.01% |
9,070
-404,892
| -98% | -$1.86M |
2018 Q3
7 quarters
|
|
4684
Teucrium Corn Fund
CORN
$129M
| $44K | ﹤0.01% |
3,544
+2,344
| +195% | +$28.5K |
2016 Q2
16 quarters
|
|
|
KRSA
4685
Korsana Biosciences, Inc. Common Stock
KRSA
$1.39B
| $44K | ﹤0.01% |
54
| – | – |
2019 Q2
4 quarters
|
|
|
SOHU
4686
Sohu.com
SOHU
$325M
| $44K | ﹤0.01% |
4,741
| – | – |
2015 Q4
18 quarters
|
|
4687
Weyco Group
WEYS
$486M
| $44K | ﹤0.01% |
2,043
-12,024
| -85% | -$234K |
2017 Q4
10 quarters
|
|
|
QTT
4688
DELISTED
Qutoutiao Inc. American Depositary Shares
QTT
| $44K | ﹤0.01% |
1,475
-33,352
| -96% | -$873K |
2020 Q1
1 quarter
|
|
|
AGTC
4689
DELISTED
Applied Genetic Technologies Corporation
AGTC
| $44K | ﹤0.01% |
+7,852
| New | +$36K |
2020 Q2
0 quarters
|
|
|
GNOG
4690
DELISTED
Golden Nugget Online Gaming, Inc. Class A Common Stock
GNOG
| $44K | ﹤0.01% |
2,661
-559,620
| -100% | -$5.69M |
2020 Q1
1 quarter
|
|
4691
Atomera
ATOM
$184M
| $43K | ﹤0.01% |
+4,821
| New | +$33K |
2020 Q2
0 quarters
|
|
4692
First Trust Global Tactical Commodity Strategy Fund
FTGC
$3.33B
| $43K | ﹤0.01% |
2,779
-110,879
| -98% | -$1.65M |
2020 Q1
1 quarter
|
|
4693
VanEck Preferred Securities ex Financials ETF
PFXF
$2.37B
| $43K | ﹤0.01% |
2,380
| – | – |
2019 Q3
3 quarters
|
|
4694
Siebert Financial
SIEB
$90.4M
| $43K | ﹤0.01% |
8,595
-6,239
| -42% | -$39.3K |
2018 Q2
8 quarters
|
|
|
SWKH
4695
DELISTED
SWK Holdings
SWKH
| $43K | ﹤0.01% |
+4,550
| New | +$45.1K |
2020 Q2
0 quarters
|
|
4696
VanEck JP Morgan EM Local Currency Bond ETF
EMLC
$4.95B
| $42K | ﹤0.01% |
1,359
-1,333
| -50% | -$39.6K |
2015 Q4
18 quarters
|
|
|
PDT
4697
John Hancock Premium Dividend Fund
PDT
$579M
| $42K | ﹤0.01% |
+3,141
| New | +$40.5K |
2020 Q2
0 quarters
|
|
|
SAGE
4698
CALL
DELISTED
Sage Therapeutics
SAGE
| $42K | ﹤0.01% |
+1,000
| New | +$36.3K |
2020 Q2
0 quarters
|
|
|
WTPI
4699
WisdomTree Equity Premium Income Fund
WTPI
$543M
| $42K | ﹤0.01% |
1,697
+447
| +36% | +$10.7K |
2020 Q1
1 quarter
|
|
4700
Cibus
CBUS
$131M
| $41K | ﹤0.01% |
166
+106
| +177% | +$23.7K |
2017 Q4
10 quarters
|
|
Similar funds
JP Morgan Chase's Q2 2020 Portfolio in Review
As of Q2 2020, JP Morgan Chase held 5,976 positions worth $518B, up 22% from $426B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
JP Morgan Chase's Q2 2020 filing shows 640 new, 2,055 increased, 2,340 reduced and 398 closed positions. Its largest new stake was JPMorgan BetaBuilders International Equity ETF: 35,626,738 shares worth $1.64B. The largest sale was iShares Core MSCI EAFE ETF, an estimated $1.8B.
By sector, the portfolio is most concentrated in Miscellaneous at 26% of assets, down from 28% a quarter earlier, followed by Technology and Financials.
- JP Morgan Chase's largest Q2 2020 buy was JPMorgan BetaBuilders International Equity ETF: 35,626,738 shares worth $1.64B.
- JP Morgan Chase added most to JPMorgan BetaBuilders Europe ETF in Q2 2020, an estimated $2.63B increase.
- JP Morgan Chase's biggest Q2 2020 reduction was iShares Core MSCI EAFE ETF, cutting an estimated $1.8B.
- JP Morgan Chase fully exited Allergan plc in Q2 2020, selling an estimated $656M.
- JP Morgan Chase's ten largest holdings make up 17% of its $518B portfolio in Q2 2020.
- JP Morgan Chase opened 640 new positions and closed 398 in Q2 2020.
- JP Morgan Chase's portfolio value rose 22% quarter-over-quarter to $518B.
Based on JP Morgan Chase's 13F filing for Q2 2020, filed 11 Aug 2020.